Hepatitis Clinical Trials

Showing 461-480 of 2,113 trials

Development of a Autoimmune Hepatitis Patient's Database Linked to a Biological Sample Storage

NCT06078098

Autoimmune Hepatitis (AIH) is chronic fibroinflammatory disease of the liver characterized by chronic, relapsing liver inflammation, and a risk for progression to liver failure and need for liver transplantation. No AIH-specific registry does exist in Italy, so that the actual epidemiology of the disease in the country is unknown. This is an observational, retrospective and prospective, multicenter study evaluating incidence, prevalence and disease course of AIH in subjects \> 1 years old in Italy.

Autoimmune HepatitisLiver Disorder

University of Milano Bicocca10,000 participantsStarted Mar 2023

Monza, MB, Italy

COMPLETED

Barriers to MASLD Management in Europe: Findings From a Multidisciplinary HCP-survey

NCT05765890

The purpose of this study is to better understand the main barriers to earlier diagnosis and better management of MASLD/MASH patients and to understand the key barriers to adoption of guidelines. This study is a cross-sectional design, conducted across 5 countries in Europe- France, Germany, Spain, United Kingdom (UK), Italy. Study participants, Hepatologists and other metabolically focused healthcare providers (HCPs), will be recruited to complete a 15 minute self-administered online survey.

Non-alcoholic Steatohepatitis (MASH)Non-alcoholic Fatty Liver Disease (MASLD)

Novo Nordisk A/S675 participantsStarted Mar 2023

Bangalore, India

COMPLETEDPhase 4

The Immunogenicity and Safety of Inactivated and Live Attenuated Hepatitis A Vaccines

NCT01949857

The purpose of this Phase 4 trial is to assess the safety, immunogenicity, three-year immune persistence of inactivated hepatitis A vaccine (HAV) and live attenuated HAV vaccine.

Hepatitis A

Institute of Medical Biology, Chinese Academy of Medical Sciences35,000 participantsStarted Sep 2013

Kunming, Yunnan, China

Development of a Autoimmune Hepatitis Patient's Database Linked to a Biological Sample Storage

Barriers to MASLD Management in Europe: Findings From a Multidisciplinary HCP-survey

The Immunogenicity and Safety of Inactivated and Live Attenuated Hepatitis A Vaccines

Related Searches

Phase 1 Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Multiple Oral Doses of MGL-3196 in Subjects With Varying Degrees of Hepatic Impairment and Healthy Matched Control Subjects

Agreement and Reliability of Transient Elastography

A Registry for Participants With Cirrhosis Who Achieve a Sustained Virologic Response Following Treatment With a Sofosbuvir-Based Regimen Without Interferon for Chronic Hepatitis C Infection

A Study to Evaluate the Antiviral Activity and Safety of HH-003 Injection in Subjects With HBeAg-Negative Chronic Hepatitis B Treated With Nucleos(t)Ide Reverse Transcriptase Inhibitors

Study to Compare Tenofovir Alafenamide (TAF) Versus Tenofovir Disoproxil Fumarate (TDF) in Participants With Chronic Hepatitis B Infection Who Are Negative for Hepatitis B e Antigen

TDF and Entekavir - Hepatitis B Reactivation

Seville Cohort of People at Substantial Risk for HIV Infection on Pre-exposure Prophylaxis

The Efficacy and Safety of Tenofovir Amibufenamide to Treat Low-level Viraemia After Entecavir Treatment

Subcutaneous Doses of CM-101 as a Treatment for Medical Conditions Involving Inflammatory and Fibrotic Mechanisms in Healthy Male Subjects

Hepatitis B Vaccination After Neonatal Surgery

Effects of T-bet B Cells in Persistent Virus Control After Discontinuance of NAs in CHB Patients

Safety and Immunotherapeutic Activity of Cemiplimab in Participants With HBV on Suppressive Antiviral Therapy

Patient Knowledge, Beliefs and Barriers to Hepatitis D Care

Hepatocellular Carcinoma in HIV-infected Individuals in Asian Population

Safety, Tolerability, and Efficacy of 12-weeks of Sovaprevir, ACH-3102, and Ribavirin in Treatment-naive GT-1 HCV Participants

A Study of Chronic Hepatitis C Patients Treated With SOF/VEL/VOX

Hepatitis C Positive Organ to Recipient Hepatitis C Negative Longitudinal Transplant Study